These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 34294629)
21. Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Usui C; Hatta K; Doi N; Kubo S; Kamigaichi R; Nakanishi A; Nakamura H; Hattori N; Arai H Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1704-8. PubMed ID: 21605615 [TBL] [Abstract][Full Text] [Related]
22. Acute Presentation of Nonmotor Symptoms in Parkinson's Disease. Kwei K; Frucht S Int Rev Neurobiol; 2017; 134():973-986. PubMed ID: 28805591 [TBL] [Abstract][Full Text] [Related]
30. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation]. Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992 [TBL] [Abstract][Full Text] [Related]
31. Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease. Ueda S; Koyama K; Okubo Y J ECT; 2010 Jun; 26(2):111-5. PubMed ID: 20386461 [TBL] [Abstract][Full Text] [Related]
32. Effects of electroconvulsive therapy on mood, parkinsonism, and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Holcomb HH; Sternberg DE; Heninger GR Biol Psychiatry; 1983 Aug; 18(8):865-73. PubMed ID: 6615944 [TBL] [Abstract][Full Text] [Related]
33. Parkinson's Disease Multimodal Complex Treatment improves motor symptoms, depression and quality of life. Scherbaum R; Hartelt E; Kinkel M; Gold R; Muhlack S; Tönges L J Neurol; 2020 Apr; 267(4):954-965. PubMed ID: 31797086 [TBL] [Abstract][Full Text] [Related]
34. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms. Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203 [TBL] [Abstract][Full Text] [Related]
35. [A 73-year-old woman with familial Parkinson's disease]. Takanashi M; Urabe T; Ohta S; Hamano Y; Mori H; Shirai T; Kondo T; Mizuno Y No To Shinkei; 1999 Dec; 51(12):1087-96. PubMed ID: 10654309 [TBL] [Abstract][Full Text] [Related]
36. The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status. Fryml LD; Williams KR; Pelic CG; Fox J; Sahlem G; Robert S; Revuelta GJ; Short EB J Psychiatr Pract; 2017 May; 23(3):191-199. PubMed ID: 28492457 [TBL] [Abstract][Full Text] [Related]
37. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment. Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092 [TBL] [Abstract][Full Text] [Related]